Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
For GLP-1s, that typically means a diagnosis of obesity (BMI 30+) or a weight-related comorbidity with a BMI 27+
Tirzepatide may cause slightly more headaches initially due to its dual receptor activation affecting both GLP-1 and GIP pathways in the brain simultaneously, though the data does not show a statistically significant difference between the two medications
Imaging was unremarkable, but after an episode of hematochezia, a colonoscopy was performed, which grossly showed signs of colonic ischemia with biopsied tissue demonstrating changes consistent with ischemic mucosa
Technical/expert advice for this project was provided by the Michigan Center for Diabetes Translational Research (Grant P30DK092926 from the National Institute of Diabetes and Digestive and Kidney Diseases) (Shihchen Kuo)
US$ 29.19
US$ 22.32
US$ 29.21
US$ 28.74
US$ 29.02
